Do Butalbital‐Containing Products Have a Role in the Management of Migraine?
- 1 August 2002
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 22 (8) , 1029-1035
Abstract
Study Objective. To evaluate the role of butalbital‐containing products in the management of migraine.Methods. Qualitative systematic search using MEDLINE (January 1966–November 2001), review of the United States Headache Consortium's evidence‐based guidelines for migraine treatment, and review of other pertinent literature.Results. Over 28 million people suffer with migraine, yet this illness is less than optimally diagnosed and managed. Between 14% and 36% of diagnosed migraineurs are prescribed butalbital‐containing products, often as initial therapy. However, the only identified controlled trial of these drugs for migraine treatment showed that butalbital‐containing products were inferior to butorphanol. The consortium's guidelines specifically discourage administration of butalbital‐containing products for migraine. In addition, other published literature highlights the frequent adverse consequences of butalbital‐containing products for migraineurs, such as poor migraine control, disability, drug‐induced headaches, and withdrawal symptoms.Conclusion. Although butalbital‐containing products commonly are prescribed for migraine, no evidence in the literature demonstrates their benefit over other agents or placebo. Drugs with proven migraine efficacy, as listed in the consortium's evidence‐based guidelines, should be prescribed instead.Keywords
This publication has 32 references indexed in Scilit:
- Mixing Sumatriptan: A Prospective Study of Stratified Care Using Multiple FormulationsHeadache: The Journal of Head and Face Pain, 2001
- Mixing Sumatriptan: A Prospective Study of Stratified Care Using Multiple FormulationsHeadache: The Journal of Head and Face Pain, 2001
- Migraine's impact todayPostgraduate Medicine, 2001
- Comparison of Butorphanol Nasal Spray and Fiorinal With Codeine in the Treatment of MigraineHeadache: The Journal of Head and Face Pain, 1998
- TRANSFORMED MIGRAINE, ANALGESIC REBOUND, AND OTHER CHRONIC DAILY HEADACHESNeurologic Clinics, 1997
- Analgesic Rebound HeadacheDrug Safety, 1995
- A Protocol for Butalbital, Aspirin and Caffeine (BAC) Detoxification in Headache PatientsHeadache: The Journal of Head and Face Pain, 1990
- HeadacheNew England Journal of Medicine, 1980
- The Use of Analgesics in HeadacheHeadache: The Journal of Head and Face Pain, 1979
- Drug Dependency in Patients with Chronic HeadachesHeadache: The Journal of Head and Face Pain, 1977